fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » GlaxoSmithkline Consumer Healthcare Ltd

GlaxoSmithkline Consumer Healthcare Ltd

Updated on May 15, 2019

Stock/Share Code - GSKCONS

GlaxoSmithKline Consumer Healthcare is a food processing company. The Company offers malt-based food, protein rich food, cereal-based beverage and nutritional food powder.

Below is the details of GSKCONS GlaxoSmithkline Consumer Healthcare Ltd

Market Cap₹30,342 Cr.
Current Price ₹7,473.2 as on 20 May 19
52 Week High / Low Price₹7,934.85 / ₹5,725
Face Value₹10
Stock P/E33.39
Book Value₹853.83
Dividend Yield1.04 %
ROCE32.53 %
ROE21.18 %
Sales Growth (3yrs)0.07 %
SectorFMCG
IndustryFood - Processing - MNC
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Company has a good return on equity (ROE) track record: 3 Years ROE 23.43% Company has been maintaining a healthy dividend payout of 44.24%
Cons: Stock is trading at 8.45 times its book value The company has delivered a poor growth of 6.25% over past five years. Earnings include an other income of Rs.393.88 Cr.

GlaxoSmithkline Consumer Healthcare Ltd Price Chart

GlaxoSmithkline Consumer Healthcare Ltd Price Chart

GlaxoSmithkline Consumer Healthcare Ltd Peer Comparison in FMCG

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Nestle India ₹10,768.15 63.84 ₹102,588.47 Cr. 0.81 ₹341.76 Cr. 9.60 11.37 2897.27 57.04
2. Britannia Inds. ₹2,801.2 65.30 ₹73,462.9 Cr. 0.41 ₹300.07 Cr. 13.81 10.71 2842.44 47.47
3. GlaxoSmith C H L ₹126.05 33.39 ₹30,342.08 Cr. 1.04 ₹221.06 Cr. 35.07 7.45 1116.82 32.53

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

GlaxoSmithkline Consumer Healthcare Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018
Sales1,0779441,0808601,1039861,1121,0391,1801,1071,2721,117
YOY Sales Growth %-11.36%-5.18%-1.05%-11.46%2.36%4.45%2.91%20.8%6.96%12.3%14.42%7.45%
Expenses864740835693885819853832930877918878
Material Cost %32.09%29.27%33.99%32.21%34.13%34.75%35.44%31.01%31.68%30.43%30.34%29.29%
Employee Cost %13.25%13.37%12.1%12.4%9.28%13.57%11.44%12.68%11.66%15.17%12.19%14.03%
Operating Profit214204245168218167259208250230354239
OPM %20%22%23%19%20%17%23%20%21%21%28%21%
Other Income5059585670555761849689124
Interest011111101000
Depreciation151515171817181515151516
Profit before tax249247288206269204298253319312427347
Tax %35%35%36%34%35%35%35%35%34%36%36%36%
Net Profit162161184136176132192164212200275221
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales1,1081,2741,5421,9212,3062,7653,1874,8694,3084,1363,9914,3174,676
Sales Growth %15.39%14.93%21.06%24.62%20.01%19.93%15.28%52.74%-11.52%-3.98%-3.51%8.15%%
Expenses9291,0491,3061,6111,9292,2612,6143,9963,5693,2983,1533,4333,603
Material Cost %24.69%25.15%27.56%28.32%29.14%28.51%28.55%28.3%34.8%32.48%26.4%27.29%%
Manufacturing Cost %18.29%17.26%18.77%15.72%14.94%14.4%14.18%13.81%6.45%3.09%9.25%8.8%%
Employee Cost %11.76%11.78%10.8%10.1%9.62%9.34%9.45%9.65%10.01%12.21%11.3%12.23%%
Other Cost %29.1%28.16%27.57%29.7%29.96%29.5%29.84%30.31%31.6%31.95%32.06%31.22%%
Operating Profit1792252363113775045738737388388388831,073
OPM %16%18%15%16%16%18%18%18%17%20%21%20%23%
Other Income5868958911785114207214278239257394
Interest4554332112321
Depreciation43434242404636636257646460
Profit before tax1912452843544525406491,0168891,0561,0101,0741,405
Tax %33%34%34%34%34%34%33%34%34%35%35%35%
Net Profit127163188233300355437675584687657700909
EPS in Rs28.7836.6442.2352.2962.9978.7896.55122.24127.57163.42156.15166.47
Dividend Payout %33%31%34%33%70%41%43%28%40%43%45%45%

Compounded Sales Growth

  • 10 Years:: 12.98%
  • 5 Years:: 6.25%
  • 3 Years:: 0.07%
  • TTM:: 10.28%

Compounded Profit Growth

  • 10 Years:: 15.72%
  • 5 Years:: 9.91%
  • 3 Years:: 5.92%
  • TTM:: 36.83%

Return on Equity

  • 10 Years:: 28.26%
  • 5 Years:: 26.95%
  • 3 Years:: 23.43%
  • TTM:: 21.18%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Sep 2018
Share Capital42424242424242424242424242
Equity Capital42.0642.0642.0642.0642.0642.0642.0642.0642.0642.0642.0642.06
Reserves5016047198639181,1021,3191,7712,0712,7573,0813,4433,549
Borrowings00000000013800
Other Liabilities7112723305248129461,2001,6151,9251,6991,8501,9541,992
Trade Payables124.36143.93172.46285356.92389.93500.32686.75781.67803.28898.621050.891009.29
Total Liabilities1,2549181,0911,4291,7722,0902,5613,4284,0384,5104,9815,4395,583
Fixed Assets251226210194202201194340492481487476486
Gross Block521.69523.67539.47558.48598.96636.66656.24854.621059.28569.43629.35650.85
Accumulated Depreciation270.32297.65329.24364396.71435.97462.4514.71567.5488.16141.93175.32
CWIP717163810814919738425158386
Investments22029800000000000
Other Assets7763778651,1971,4611,7412,1703,0503,5043,9774,4364,9265,091
Inventories145.57194.82277.17266.03312369.96369.64407.42466.25461.62461.14409.42386.12
Trade receivables28.0927.3643.2531.3650.3799.19112.61299.35313.36354.16321278.72338.1
Cash Equivalents47.9293.67470.98819.8976.11079.661464.241838.782296.522712.273087.383585.23854.81
Loans n Advances554.961.3673.6179.56122.92141.28164.93315.23351.72357.38423.42430.7545.98
Total Assets1,2549181,0911,4291,7722,0902,5613,4284,0384,5104,9815,4395,583

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity139188135400326391554644611573603723
Profit from operations216.89266.69295.94371.06446.91526.97592.86914.15787.34872.06899.08929.77
Working Capital Changes-4.16-13.57-57.12168.773944.69185.6763.23120.1353.4124.06260.21
Taxes paid-74.15-65.06-104.1-139.84-159.7-180.93-224.21-332.88-296-352-420.16-466.94
Cash from Investing Activity-225-2119-22-79-125-377-271331-152-602-446
Fixed Assets Purchased-19.33-25.47-30.71-46.29-114.3-97.8-83.74-168.59-107.43-54.53-68.29-51.39
Fixed Assets Sold0.880.281.391.025.672.551.861.081.772.42.571.99
Investments purchased-219.68-200000000000
Investments sold0022.29000000000
Cash from Financing Activity-52-63-55-30-91-248-175-223-222-286-361-363
Interest Paid-3.21-4.28-5.36-4.77-2.45-2.86-4.4-1.29-0.74-2.28-2.78-2.03
Dividends Paid-42.6-50.4-42.06-21.25-75.5-210.28-147.19-189.25-189.25-231.31-294.23-293.09
Net Cash Flow-13810499349156172150720136-361-87

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %38%42%41%43%48%52%52%64%46%43%34%33%
Debtor Days98106813132227312924
Inventory Turnover8.017.486.537.077.988.118.6212.539.868.928.659.92

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in GlaxoSmithkline Consumer Healthcare Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.